ACZ885D
Biological
Novartis Pharma AG
Total Payments
$23,437
Transactions
10
Doctors
4
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $6,300 | 1 | 1 |
| 2017 | $17,137 | 9 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,526 | 5 | 57.7% |
| Unspecified | $6,300 | 1 | 26.9% |
| Travel and Lodging | $3,538 | 3 | 15.1% |
| Food and Beverage | $73.12 | 1 | 0.3% |
Payments by Type
General
$17,137
9 transactions
Research
$6,300
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ACZ885D/P1001834/h50 | Novartis Pharma AG | $6,300 | 1 |
Top Doctors Receiving Payments for ACZ885D
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Clinical Pharmacology | San Luis Obispo, CA | $8,569 | 6 |
| , M.D | Rheumatology | Boston, MA | $6,828 | 2 |
| John Scott | Infectious Disease | Seattle, WA | $6,300 | 1 |
| Norman Ilowite | — | Bronx, NY | $1,740 | 1 |
Ad
Manufacturing Companies
- Novartis Pharma AG $23,437
Product Information
- Type Biological
- Total Payments $23,437
- Total Doctors 4
- Transactions 10
About ACZ885D
ACZ885D is a biological associated with $23,437 in payments to 4 healthcare providers, recorded across 10 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2018. In 2018, $6,300 was paid across 1 transactions to 1 doctors.
The most common payment nature for ACZ885D is "Consulting Fee" ($13,526, 57.7% of total).
ACZ885D is associated with 1 research study, including "ACZ885D/P1001834/h50" ($6,300).